Nintedanib bei progressiver Nicht-IPF-Lungenfibrose – eine SubgruppenanalyseNintedanib in progressive non-IPF pulmonary fibrosis—A subgroup analysis

被引：0
|
作者：
Philipp Markart
机构：
[1] Universitätsmedizin Marburg,Medizinische Klinik V (Pneumologie), Herzthoraxzentrum, Klinikum Fulda gAG
[2] Campus Fulda,Medizinische Klinik und Poliklinik II
[3] Universitätsklinikum Gießen und Marburg GmbH,undefined
[4] Standort Gießen,undefined
来源：
Der Pneumologe | 2020年 / 17卷 / 5期
关键词：
D O I：
10.1007/s10405-020-00341-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：350 / 351
页数：1
相关论文
共 41 条
  • [31] A systematic review and meta-analysis of the clinical benefits and adverse reactions of anti-fibrotics in non-IPF progressive fibrosing ILD
    Chong, Woon Hean
    Agrawal, Dipika
    Tan, Ze Ying
    Venkateswaran, Sridhar
    Tan, Adeline Yit Ying
    Tan, Ching Yee
    Ling, Norris Chun Ang
    Tay, Noel Stanley Wey Tut
    HEART & LUNG, 2024, 68 : 242 - 253
  • [32] PTEN Expression in Progressive (Idiopathic Pulmonary Fibrosis-IPF) Versus Non-Progressive (Sub-Pleural Fibrosis in Recurrent Spontaneous Pneumothorax-RSP) Pulmonary Fibrosis
    Nudelman, R. J.
    Schutte, S.
    Lan, R.
    Leslie, K. O.
    Jagirdar, J.
    LABORATORY INVESTIGATION, 2012, 92 : 485A - 485A
  • [33] Imaging Signature Idiopathic Pulmonary Fibrosis (IS-IPF): An Analytic Validation Study of Two CT Image-based Biomarkers in an Independent Cohort for Predicting Disease Progression in Non-IPF Interstitial Lung Diseases
    Kim, G. J.
    Song, J.
    Oh, J.
    Weigt, S.
    Wilkinson, J.
    Villegas, B.
    Abtin, F.
    Pourzand, L.
    Lee, J.
    Lee, K.
    Goldin, J. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [34] Safety Of The Combined Use Of Pirfenidone And Nintedanib In Patients With Idiopathic Pulmonary Fibrosis (ipf): Results From An Interim Analysis After 12 Weeks
    Flaherty, K. R.
    Sussman, R.
    Pesci, A.
    Nunes, H.
    Acosta, O.
    Petzinger, U.
    Stauffer, J.
    Gilberg, F.
    Bengus, M.
    Lancaster, L. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [35] COST EFFECTIVENESS ANALYSIS OF PIRFENIDONE FOR THE TREATMENT OF MILD TO MODERATE IDIOPATHIC PULMONARY FIBROSIS (IPF) COMPARED TO BEST SUPPORTIVE CARE AND NINTEDANIB FROM THE ITALIAN NHS PERSPECTIVE
    Ravasio, R.
    Ferrario, M.
    Pata, M.
    Thuresson, P.
    VALUE IN HEALTH, 2016, 19 (07) : A556 - A556
  • [36] Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and non-specific interstitial pneumonia (NSIP)
    Korfei, Martina
    Henneke, Ingrid
    Markart, Philipp
    Von Der Beck, Daniel
    Ruppert, Clemens
    Mahavadi, Poornima
    Klepetko, Walter
    Fink, Ludger
    Meiners, Silke
    Kraemer, Oliver
    Seeger, Werner
    Vancheri, Carlo
    Guenther, Andreas
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [37] Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial
    Jürgen Behr
    Petra Neuser
    Antje Prasse
    Michael Kreuter
    Klaus Rabe
    Carmen Schade-Brittinger
    Jasmin Wagner
    Andreas Günther
    BMC Pulmonary Medicine, 17
  • [38] Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial
    Behr, Juergen
    Neuser, Petra
    Prasse, Antje
    Kreuter, Michael
    Rabe, Klaus
    Schade-Brittinger, Carmen
    Wagner, Jasmin
    Guenther, Andreas
    BMC PULMONARY MEDICINE, 2017, 17
  • [39] Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP) and organ donors
    Korfei, Martina
    von der Beck, Daniel
    Henneke, Ingrid
    Markart, Philipp
    Ruppert, Clemens
    Mahavadi, Poornima
    Ghanim, Bahil
    Klepetko, Walter
    Fink, Ludger
    Meiners, Silke
    Kraemer, Oliver Holger
    Seeger, Werner
    Vancheri, Carlo
    Guenther, Andreas
    JOURNAL OF PROTEOMICS, 2013, 85 : 109 - 128
  • [40] A Comparative Analysis Of Rates Of Diagnosis, Treatment Initiation, And Treatment Persistence In Idiopathic Pulmonary Fibrosis (ipf) Versus Non-Small-Cell Lung Cancer (nsclc)
    Denton, J.
    Phillips, C.
    Del Carlo, A.
    Mavaddat, A.
    Carter, E.
    Dejonckheere, F.
    Munk, V. C.
    Molnar, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
12345